Skip to content

VBIO VALION BIO INC

Follow

COM (common), issuer CIK 1787740

Filings received so far for Q3 2026: 8 13F filers report a position in VBIO shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.

13D and 13G filers

Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.

  • 3i, LP
    137,282 shares, 9.9% in a 13G/A as of 2026-09-30,0001104659-26-126218
    Accepted , ingested

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2026

Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Marex Group Ltdin group Marex Group Ltd94,385$264K<0.01%new13F-HRTimelineGroup
Murchinson Ltd.in group Murchinson Ltd.31,830$89.1K0.05%new13F-HRTimelineGroup
UBS Group AGin group UBS Group AG9,048$25.3K<0.01%new13F-HRTimelineGroup
Tower Research Capital LLC (TRC)in group Tower Research Capital LLC (T…2,687$7.52K<0.01%new13F-HRTimelineGroup
Robinhood Markets, Inc.in group Robinhood Markets, Inc.707$1.97K<0.01%13F-HRTimelineGroup
SBI Securities Co., Ltd.53$148<0.01%new13F-HRTimeline
DANSKE BANK A/S1$3<0.01%new13F-HRTimeline
Caitong International Asset Management …1$3<0.01%new13F-HRTimeline

Events

  • 3i, LP and 3 other reporting persons reported 137,282 VBIO shares, 9.9% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-12. 0001104659-26-126218

    Accepted , ingested